Acquisition of Respiratory System Medications, under CPA 2024/899, for ULSASI, for the year 2026

This tender seeks the acquisition of medications for the respiratory system. The procurement is conducted under the framework agreement CPA 2024/899 and is intended for the ULSASI (Unidade Local de Saúde do Alto do Sado, likely) for the year 2026. The scope includes a range of pharmaceutical products necessary for treating respiratory conditions. Bidders are required to supply medications that meet specific quality standards and regulatory requirements. This procurement is crucial for ensuring the continuous availability of essential respiratory medicines for healthcare services provided by ULSASI, supporting patient care and treatment protocols throughout the specified year.

This is a supplies contract in the health and medical services, trade and industry and general supplies sectors. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 2,764.

Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.